Regenicin, Inc.

RGIN · OTC
Analyze with AI
3/31/2023
12/31/2022
9/30/2022
6/30/2022
Operating Activities
Net Income-$336-$278-$155-$163
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$94$146$143
Other Non-Cash$9$10$9$10
Operating Cash Flow-$328-$362-$0-$10
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$13$10
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$13,119$12,141$0$0
Financing Cash Flow-$13,119$12,141$13$10
Forex Effect$0$0$0$0
Net Chg. in Cash-$914$11,779$13-$0
Supplemental Information
Beg. Cash$11,794$15$2$2
End Cash$10,880$11,794$15$2
Free Cash Flow-$328-$362-$0-$10